Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Delaware Law-Proxy Access
1
Sep 30, 2010 10:35PM

Please note bolded (so easily overlooked):

New Section 112 of the DGCL allows, but does not require, a Delaware corporation to adopt bylaws that provide that if the corporation solicits proxies for the election of directors, stockholders have the right to include stockholders’ nominees for director in the corporation’s proxy materials, including the form of proxy

.

.

.

Be well

Share
New Message
Please login to post a reply